This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Storgaard, H. Articles by Vaag, A. A. Search for Related Content PubMed PubMed Citation Articles by Storgaard, H. Articles by Vaag, A. A.

Dissociation between Fat-Induced in Vivo Insulin Resistance and Proximal Insulin Signaling in Skeletal Muscle in Men at Risk for Type 2 Diabetes

Department of Endocrinology and Clinical Research Unit (H.S., C.B.J., S.M., A.A.V.), Hvidovre Hospital, University of Copenhagen, DK-2650 Hvidovre, Denmark; Department of Clinical Physiology (M.B., X.M.S., J.R.Z.), Karolinska Hospital, Karolinska Institutet, SE 17177 Stockholm, Sweden; and Steno Diabetes Center (A.A.V.), 2820 Gentofte, Denmark

Address all correspondence and requests for reprints to: Heidi Storgaard, Steno Diabetes Center, Niels Steensensvej 2, 2820 Gentofte, Denmark. E-mail: heis{at}steno.dk or hstorgaard{at}dadlnet.dk.

The effect of short- (2 h) and long-term (24 h) low-grade Intralipid infusion on whole-body insulin action, cellular glucose metabolism, and proximal components of the insulin signal transduction cascade was studied in seven obese male glucose intolerant first degree relatives of type 2 diabetic patients [impaired glucose tolerance (IGT) relatives] and eight matched control subjects.

Indirect calorimetry and excision of vastus lateralis skeletal muscle biopsies were performed before and during hyperinsulinemic euglycemic clamps combined with 3[³H]glucose. Clamps were performed after 0, 2, or 24 h Intralipid infusion (0.4 ml·kg^-1·min^-1).

Insulin-stimulated glucose disposal decreased approximately 25% after short- and long-term fat infusion in both IGT relatives and controls. Glucose oxidation decreased and lipid oxidation increased after both short- and long-term fat infusion in both groups. Insulin-stimulated glucose oxidation was higher after long-term as compared with short-term fat infusion in control subjects. Short- or long-term infusion did not affect the absolute values of basal or insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation, tyrosine-associated phosphoinositide 3-kinase (PI 3-kinase) activity, insulin receptor substrate-1-associated PI 3-kinase activity, or Akt serine phosphorylation in IGT relatives or matched controls. In fact, a paradoxical increase in both basal and insulin-stimulated PI 3-kinase activity was noted in the total study population after both short- and long-term fat infusion.

Short- and long-term low-grade Intralipid infusion-induced (or enhanced) whole-body insulin resistance and impaired glucose metabolism in IGT relatives and matched control subjects. The fat-induced metabolic changes were not explained by impairment of the proximal insulin signaling transduction in skeletal muscle.

This work was supported by grants from the Novo-Nordisk Foundation; Danish Research Council; Danish Diabetes Association; Association of Danish Female Doctors; Grosserer C. P. Frederiksens Foundation, Beckett Foundation; Direktør E. Danielsen and Wife’s Foundation; Eli Lilly’s Diabetes Research Foundation; Handelsgartner Ove V. B. Olsen’s and Edith B. Olsen’s Foundation; Ebba Celinders Foundation; Christian the 3rd Foundation; H:S Research Foundation; the Swedish Medical Research Council; and the Swedish Diabetes Association. H.S. was granted a research fellowship scholarship from the Faculty of Medicine, University of Copenhagen, Denmark.

Abbreviations: DTT, Dithiothreitol; ECL, enhanced chemiluminescence; EGP, endogenous glucose production; EGS, exogenous glucose storage; FFA, free fatty acid; GF, glycolytic flux; GOX, glucose oxidation; IGT, impaired glucose tolerance; IR, insulin receptor; IRS, IR substrate; IVGTT, intravenous glucose tolerance test; LIPOX, lipid oxidation; NOGM, nonoxidative glucose metabolism; OGTT, oral glucose tolerance test; PI 3-kinase, phosphoinositide 3-kinase; PVDF, polyvinylidene difluoride; Ra, glucose appearance rate; Rd, glucose disposal rate; SA, specific activity.

This article has been cited by other articles:

				L. C. Chao, K. Wroblewski, Z. Zhang, L. Pei, L. Vergnes, O. R. Ilkayeva, S. Y. Ding, K. Reue, M. J. Watt, C. B. Newgard, et al. Insulin Resistance and Altered Systemic Glucose Metabolism in Mice Lacking Nur77 Diabetes, December 1, 2009; 58(12): 2788 - 2796. [Abstract] [Full Text] [PDF]

				C. Brøns and A. Vaag Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes J. Physiol., August 15, 2009; 587(16): 3977 - 3978. [Full Text] [PDF]

				B. Vistisen, L. I Hellgren, T. Vadset, C. Scheede-Bergdahl, J. W. Helge, F. Dela, and B. Stallknecht Effect of gender on lipid-induced insulin resistance in obese subjects Eur. J. Endocrinol., January 1, 2008; 158(1): 61 - 68. [Abstract] [Full Text] [PDF]

				L. K. Heilbronn, S. Gregersen, D. Shirkhedkar, D. Hu, and L. V. Campbell Impaired Fat Oxidation After a Single High-Fat Meal in Insulin-Sensitive Nondiabetic Individuals With a Family History of Type 2 Diabetes Diabetes, August 1, 2007; 56(8): 2046 - 2053. [Abstract] [Full Text] [PDF]

				L. C. Gormsen, N. Jessen, J. Gjedsted, S. Gjedde, H. Norrelund, S. Lund, J. S. Christiansen, S. Nielsen, O. Schmitz, and N. Moller Dose-Response Effects of Free Fatty Acids on Glucose and Lipid Metabolism during Somatostatin Blockade of Growth Hormone and Insulin in Humans J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1834 - 1842. [Abstract] [Full Text] [PDF]

				K. Tsintzas, K. Jewell, M. Kamran, D. Laithwaite, T. Boonsong, J. Littlewood, I. Macdonald, and A. Bennett Differential regulation of metabolic genes in skeletal muscle during starvation and refeeding in humans J. Physiol., August 15, 2006; 575(1): 291 - 303. [Abstract] [Full Text] [PDF]

				A. Wiederkehr and C. B. Wollheim Minireview: Implication of Mitochondria in Insulin Secretion and Action Endocrinology, June 1, 2006; 147(6): 2643 - 2649. [Abstract] [Full Text] [PDF]

				L. C Gormsen, J. Gjedsted, S. Gjedde, E. T. Vestergaard, J. S Christiansen, J. O. Jorgensen, S. Nielsen, and N. Moller Free fatty acids decrease circulating ghrelin concentrations in humans. Eur. J. Endocrinol., May 1, 2006; 154(5): 667 - 673. [Abstract] [Full Text] [PDF]

				M. Bajaj, S. Suraamornkul, A. Romanelli, G. W. Cline, L. J. Mandarino, G. I. Shulman, and R. A. DeFronzo Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long-Chain Fatty Acyl-CoAs and Insulin Action in Type 2 Diabetic Patients Diabetes, November 1, 2005; 54(11): 3148 - 3153. [Abstract] [Full Text] [PDF]

				G. K. Bandyopadhyay, J. G. Yu, J. Ofrecio, and J. M. Olefsky Increased p85/55/50 Expression and Decreased Phosphotidylinositol 3-Kinase Activity in Insulin-Resistant Human Skeletal Muscle Diabetes, August 1, 2005; 54(8): 2351 - 2359. [Abstract] [Full Text] [PDF]

				R. Belfort, L. Mandarino, S. Kashyap, K. Wirfel, T. Pratipanawatr, R. Berria, R. A. DeFronzo, and K. Cusi Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling Diabetes, June 1, 2005; 54(6): 1640 - 1648. [Abstract] [Full Text] [PDF]